Fleming P, Kraft J, Gulliver WP, et al
of the CY 2026 OPPS/ASC proposed rule, we also proposed that if more recent data are subsequently available (for example, a more recent estimate of the PPI for Pharmaceuticals for Human Use, Prescription), we would use such data, if appropriate, to determine the CY 2026 diagnostic radiopharmaceutical packaging threshold in the final rule
Similarly, committee member Bill Zamboni expressed his concerns, stating, "There are too many unknowns about this product." On the other hand, PCAC member David Pope from XiFin Pharmacy Solutions stated, "I voted yes because it's time to put this decision back in the hands of the physician and pharmacist."
Its popularity is rising, particularly on the internet and in wellness clinics
Without neurological symptoms, around 3 injections over 2 to 3 weeks is standard